MarketCap
Facebook
X
Telegram
Land |
 Belgien |
IPO-Jahr |
2015 |
Branche |
Pharmaeinzelhändler |
Börse |
NASDAQ GLOBAL |
Anteile |
65.9 M |
Marktkapitalisierung |
$ 1.83 B |
EBITDA (LTM) |
$ 117 M |
P/E (LTM) |
3.5 |
P/S (LTM) |
1.52 |
EPS (LTM) |
8.22 |
Andere Aktien der Branche "Pharmaeinzelhändler"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
 |
Biofrontera AG
BFRA
|
- | -8.24 % | $ 105 M | Nasdaq Capital Market |  Germany |
 |
Bicycle Therapeutics plc
BCYC
|
$ 3.55 | -2.47 % | $ 246 M | Nasdaq Global Select Market |  Britain |
 |
Catabasis Pharmaceuticals, Inc.
CATB
|
- | -6.97 % | $ 657 M | Nasdaq Global Market |  USA |
 |
Beam Therapeutics
BEAM
|
$ 24.05 | -2.08 % | $ 2.38 B | Nasdaq Global Select Market | USA |
 |
China Biologic Products Holdings, Inc.
CBPO
|
- | 1.68 % | $ 4.65 B | Nasdaq Global Select Market |  China |
 |
Benitec Biopharma
BNTC
|
$ 8.65 | -1.93 % | $ 403 M | Nasdaq Capital Market | USA |
 |
BioNTech SE
BNTX
|
$ 88.12 | -1.73 % | $ 21.3 B | Nasdaq Global Select Market | Germany |
 |
ANI Pharmaceuticals
ANIP
|
$ 72.61 | -1.55 % | $ 1.46 B | Nasdaq Global Market,SPB | USA |
 |
C4 Therapeutics
CCCC
|
$ 3.06 | -3.77 % | $ 254 M | Nasdaq Global Select Market | USA |
 |
Cerus Corporation
CERS
|
$ 2.33 | 0.87 % | $ 444 M | Nasdaq Global Market | USA |
 |
Certara
CERT
|
$ 10.33 | 2.38 % | $ 1.66 B | Nasdaq Global Select Market | USA |
 |
Flexion Therapeutics, Inc.
FLXN
|
- | - | $ 459 M | Nasdaq Global Market | USA |
 |
Coherus BioSciences
CHRS
|
$ 1.01 | -3.81 % | $ 118 M | Nasdaq Global Market | USA |
 |
Corcept Therapeutics Incorporated
CORT
|
$ 85.86 | -20.13 % | $ 8.92 B | Nasdaq Capital Market,SPB | USA |
 |
CorMedix
CRMD
|
$ 7.85 | -3.09 % | $ 565 K | Nasdaq Global Market | USA |
 |
CRISPR Therapeutics AG
CRSP
|
$ 49.39 | -1.2 % | $ 4.44 B | Nasdaq Global Market,SPB |  Schweiz |
 |
Greenwich LifeSciences
GLSI
|
$ 16.03 | 3.55 % | $ 217 M | Nasdaq Capital Market | USA |
 |
Champions Oncology
CSBR
|
$ 4.72 | -0.84 % | $ 65.3 M | Nasdaq Capital Market | USA |
 |
Heat Biologics, Inc.
HTBX
|
- | -5.76 % | $ 99.8 M | Nasdaq Capital Market | USA |
 |
Cue Biopharma
CUE
|
$ 18.66 | -1.22 % | $ 1.77 B | Nasdaq Capital Market,SPB | USA |
 |
Kindred Biosciences, Inc.
KIN
|
- | 0.11 % | $ 419 M | Nasdaq Global Select Market | USA |
 |
DBV Technologies S.A.
DBVT
|
$ 9.75 | 0.72 % | $ 1.36 B | Nasdaq Global Select Market |  France |
 |
Alterity Therapeutics Limited
ATHE
|
$ 2.09 | -2.79 % | $ 13.4 B | Nasdaq Capital Market |  Australia |
 |
Shineco, Inc.
TYHT
|
- | -3.90 % | $ 97.2 M | Nasdaq Global Select Market | China |
 |
Actinium Pharmaceuticals
ATNM
|
$ 1.52 | -2.56 % | $ 47.4 M | NYSE American | USA |
 |
Millendo Therapeutics, Inc.
MLND
|
- | -5.36 % | $ 20.2 M | Nasdaq Global Select Market | USA |
 |
DiaMedica Therapeutics
DMAC
|
$ 8.72 | 1.04 % | $ 410 M | Nasdaq Capital Market | USA |
 |
Aytu BioScience
AYTU
|
$ 1.9 | -4.04 % | $ 23.4 M | Nasdaq Capital Market | USA |
 |
Dyadic International
DYAI
|
$ 0.4 | -0.75 % | $ 14.5 M | Nasdaq Capital Market | USA |
 |
Intec Pharma Ltd
NTEC
|
- | -12.45 % | $ 17.7 M | Nasdaq Capital Market |  Israel |
 |
Edesa Biotech
EDSA
|
$ 2.77 | 0.36 % | $ 15.7 M | Nasdaq Capital Market | USA |
 |
Progenity, Inc.
PROG
|
- | -3.47 % | $ 164 M | Nasdaq Global Select Market | USA |
 |
Lantern Pharma
LTRN
|
$ 0.64 | -0.83 % | $ 6.97 M | Nasdaq Global Select Market | USA |
 |
Strongbridge Biopharma plc
SBBP
|
- | 1.52 % | $ 136 M | Nasdaq Global Select Market | USA |
 |
Fennec Pharmaceuticals
FENC
|
$ 10.08 | -2.33 % | $ 288 M | Nasdaq Capital Market | USA |
 |
Seneca Biopharma, Inc.
SNCA
|
- | -1.19 % | $ 28.7 M | Nasdaq Capital Market | USA |
 |
Cardiff Oncology
CRDF
|
$ 0.91 | -2.23 % | $ 60.8 M | Nasdaq Capital Market | USA |
 |
Inhibrx
INBX
|
$ 93.38 | -3.83 % | $ 4.4 B | Nasdaq Global Select Market | USA |
 |
Eton Pharmaceuticals
ETON
|
$ 50.0 | -0.04 % | $ 1.35 B | Nasdaq Global Market | USA |
 |
ImmuCell Corporation
ICCC
|
$ 10.25 | -1.82 % | $ 92.5 M | Nasdaq Global Select Market | USA |
 |
Fulcrum Therapeutics
FULC
|
$ 3.68 | -0.14 % | $ 233 M | Nasdaq Global Market | USA |
 |
Kamada Ltd.
KMDA
|
$ 7.77 | 0.52 % | $ 448 M | Nasdaq Global Select Market | Israel |
 |
IDEAYA Biosciences
IDYA
|
$ 34.71 | -3.9 % | $ 3.07 B | Nasdaq Global Select Market | USA |
 |
InflaRx N.V.
IFRX
|
$ 1.56 | 1.96 % | $ 105 M | Nasdaq Global Select Market | Germany |
 |
Immutep Limited
IMMP
|
$ 3.2 | 1.91 % | $ 4.66 B | Nasdaq Global Market | Australia |
 |
Mustang Bio
MBIO
|
$ 0.37 | 0.22 % | $ 1.82 M | Nasdaq Global Market | USA |
 |
Kala Pharmaceuticals
KALA
|
$ 0.19 | 2.48 % | $ 1.55 M | Nasdaq Global Select Market | USA |
 |
Mereo BioPharma Group plc
MREO
|
$ 0.28 | -1.98 % | $ 223 M | Nasdaq Global Select Market | Britain |
 |
Kiniksa Pharmaceuticals, Ltd.
KNSA
|
$ 76.73 | -5.03 % | $ 5.69 B | Nasdaq Global Select Market | USA |
 |
Karyopharm Therapeutics
KPTI
|
$ 0.52 | -5.24 % | $ 5.69 K | Nasdaq Global Select Market | USA |